Ana Claudia C de Ornelas Maia1, Gastão Soares-Filho, Valeska Pereira, Antonio Egidio Nardi, Adriana Cardoso Silva. 1. Laboratory of Panic and Respiration, Institute of Psychiatry (Drs Soares-Filho and Silva and Mss Ornelas Maia and Pereira) and National Institute for Science and Technology, Translational Medicine (Drs Nardi and Silva), Federal University of Rio de Janeiro; and National Institute for Science and Technology, Translational Medicine, Federal University Fluminense (Dr Silva), Rio de Janeiro, Brazil.
Abstract
OBJECTIVE: To systematically review the literature with regard to psychiatric disorders and quality of life in patients with an implantable cardioverter defibrillator. DATA SOURCES: Research was conducted in 3 databases (ISI Web of Science, PubMed, and PsycINFO) using the terms implantable, cardioverter, defibrillator, quality of life, psych *, anxiety, and depression. STUDY SELECTION: The search yielded 1,399 references. Non-English and repeated references were excluded. After abstract analysis, 42 references were recovered for full-text reading, and 25 articles were selected for this review. DATA EXTRACTION: Research took place in April 2012, and no time restriction was placed on any of the database searches. Review or theoretical articles were excluded, and only clinical trials and epidemiologic studies were selected for this review. RESULTS: A systematic review of the literature revealed mostly observational prospective cohort studies followed by cross-sectional observational studies and randomized clinical trials. Few studies included in the review were observational retrospective cohort or case-control studies. There are prominent signs and symptoms of anxiety and depression in patients with an implantable cardioverter defibrillator. Disorders include phobic anxiety, posttraumatic stress disorder, panic disorder, somatoform disorder, agoraphobia, and depression. Quality of life in the physical, social, and psychological domains is affected and is related to the intensity and the frequency of the device's electrical discharge. CONCLUSIONS: Work regarding psychiatric comorbidity in patients with an implantable cardioverter defibrillator has shown that anxiety and depression are common. The patients and their families should be informed by their doctors that the presence of the device minimizes risk of sudden death and allows them to have a normal life.
OBJECTIVE: To systematically review the literature with regard to psychiatric disorders and quality of life in patients with an implantable cardioverter defibrillator. DATA SOURCES: Research was conducted in 3 databases (ISI Web of Science, PubMed, and PsycINFO) using the terms implantable, cardioverter, defibrillator, quality of life, psych *, anxiety, and depression. STUDY SELECTION: The search yielded 1,399 references. Non-English and repeated references were excluded. After abstract analysis, 42 references were recovered for full-text reading, and 25 articles were selected for this review. DATA EXTRACTION: Research took place in April 2012, and no time restriction was placed on any of the database searches. Review or theoretical articles were excluded, and only clinical trials and epidemiologic studies were selected for this review. RESULTS: A systematic review of the literature revealed mostly observational prospective cohort studies followed by cross-sectional observational studies and randomized clinical trials. Few studies included in the review were observational retrospective cohort or case-control studies. There are prominent signs and symptoms of anxiety and depression in patients with an implantable cardioverter defibrillator. Disorders include phobic anxiety, posttraumatic stress disorder, panic disorder, somatoform disorder, agoraphobia, and depression. Quality of life in the physical, social, and psychological domains is affected and is related to the intensity and the frequency of the device's electrical discharge. CONCLUSIONS: Work regarding psychiatric comorbidity in patients with an implantable cardioverter defibrillator has shown that anxiety and depression are common. The patients and their families should be informed by their doctors that the presence of the device minimizes risk of sudden death and allows them to have a normal life.
Authors: William Whang; Christine M Albert; Samuel F Sears; Rachel Lampert; Jamie B Conti; Paul J Wang; Jagmeet P Singh; Jeremy N Ruskin; James E Muller; Murray A Mittleman Journal: J Am Coll Cardiol Date: 2005-04-05 Impact factor: 24.094
Authors: Agnieszka Maryniak; Lukasz Szumowski; Michał Orczykowski; Andrzej Przybylski; Franciszek Walczak Journal: Int J Cardiol Date: 2007-12-03 Impact factor: 4.164
Authors: Alexander Crössmann; Paul Pauli; Wilhelm Dengler; Volker Kühlkamp; Georg Wiedemann Journal: Heart Lung Date: 2007 Mar-Apr Impact factor: 2.210
Authors: Arwa Younis; Ilan Goldenberg; Shamroz Farooq; Hagai Yavin; James Daubert; Merritt Raitt; Alexander Mazur; David T Huang; Brent L Mitchell; Mayer R Rashtian; Stephen Winters; Margot Vloka; Mehmet Aktas; Matthew A Bernabei; Christopher A Beck; Scott McNitt; Wojciech Zareba Journal: JACC Clin Electrophysiol Date: 2022-04-27
Authors: Shireen Saxena; Ilan Goldenberg; Scott McNitt; Eileen Hsich; Valentina Kutyifa; Nicola Luigi Bragazzi; Bronislava Polonsky; Mehmet K Aktas; David T Huang; Spencer Rosero; Helmut Klein; Wojciech Zareba; Arwa Younis Journal: JAMA Netw Open Date: 2022-06-01